Antonio Dominguez-Meijide
Overview
Explore the profile of Antonio Dominguez-Meijide including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lage L, Rodriguez-Perez A, Labandeira-Garcia J, Dominguez-Meijide A
Neurotherapeutics
. 2025 Feb;
22(2):e00544.
PMID: 39915220
ROCK inhibitors such as fasudil protected against dopaminergic degeneration and other neurodegenerative processes in several experimental models through inhibition of neuroinflammation and activation of survival signaling pathways, and clinical trials...
2.
Lage L, Rodriguez-Perez A, Labandeira-Garcia J, Dominguez-Meijide A
Front Immunol
. 2024 Nov;
15:1457459.
PMID: 39588364
Angiotensin, through its type-1 receptor (AT1), is a major inducer of inflammation and oxidative stress, contributing to several diseases. Autoimmune processes have been involved in neurodegeneration, including Parkinson's disease (PD)....
3.
Dominguez-Meijide A, Vasili E, Outeiro T
Brain Sci
. 2024 Sep;
14(9).
PMID: 39335445
There was an error in the original publication [...].
4.
Lage L, Rodriguez-Perez A, Villar-Cheda B, Labandeira-Garcia J, Dominguez-Meijide A
NPJ Parkinsons Dis
. 2024 Feb;
10(1):37.
PMID: 38368444
The brain renin-angiotensin system (RAS) has been related to dopaminergic degeneration, and high expression of the angiotensin II (AngII) type 1 receptor (AT1) gene is a marker of the most...
5.
Farzadfard A, Konig A, Petersen S, Nielsen J, Vasili E, Dominguez-Meijide A, et al.
J Biol Chem
. 2022 Mar;
298(5):101848.
PMID: 35314196
Glycation is a nonenzymatic posttranslational modification (PTM) known to be increased in the brains of hyperglycemic patients. Alpha-synuclein (αSN), a central player in the etiology of Parkinson's disease, can be...
6.
Vasili E, Dominguez-Meijide A, Flores-Leon M, Al-Azzani M, Kanellidi A, Melki R, et al.
Mol Neurobiol
. 2022 Jan;
59(2):1273-1284.
PMID: 34984585
Parkinson's disease is a progressive neurodegenerative disorder characterized by the accumulation of misfolded alpha-synuclein in intraneuronal inclusions known as Lewy bodies and Lewy neurites. Multiple studies strongly implicate the levels...
7.
Medina L, Gonzalez-Lizarraga F, Dominguez-Meijide A, Ploper D, Parrales V, Sequeira S, et al.
Front Aging Neurosci
. 2021 Apr;
13:635760.
PMID: 33828477
Tauopathies are neurodegenerative disorders with increasing incidence and still without cure. The extensive time required for development and approval of novel therapeutics highlights the need for testing and repurposing known...
8.
Dominguez-Meijide A, Parrales V, Vasili E, Gonzalez-Lizarraga F, Konig A, Lazaro D, et al.
Neurobiol Dis
. 2021 Jan;
151:105256.
PMID: 33429042
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are neurodegenerative disorders characterized by the misfolding and aggregation of alpha-synuclein (aSyn). Doxycycline, a tetracyclic antibiotic shows neuroprotective effects, initially proposed...
9.
Dominguez-Meijide A, Vasili E, Outeiro T
Brain Sci
. 2020 Nov;
10(11).
PMID: 33203009
Tauopathies are neurodegenerative disorders characterized by the deposition of aggregates composed of abnormal tau protein in the brain. Additionally, misfolded forms of tau can propagate from cell to cell and...
10.
Dominguez-Meijide A, Vasili E, Konig A, Cima-Omori M, de Opakua A, Leonov A, et al.
Sci Rep
. 2020 Aug;
10(1):12827.
PMID: 32732936
Parkinson's disease (PD) and Alzheimer's disease (AD) are common neurodegenerative disorders of the elderly and, therefore, affect a growing number of patients worldwide. Both diseases share, as a common hallmark,...